Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang, Christopher D. Hillyer, Lanying Du
Trends in Immunology (2020) Vol. 41, Iss. 5, pp. 355-359
Open Access | Times Cited: 913

Showing 1-25 of 913 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani, Christian Gaebler, Frauke Muecksch, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 437-442
Open Access | Times Cited: 2018
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1536
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 643-650
Open Access | Times Cited: 1271
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Chee Wah Tan, Wan Ni Chia, Xijian Qin, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 9, pp. 1073-1078
Open Access | Times Cited: 1252
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 443-449
Open Access | Times Cited: 1107
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti, Ysrafil Ysrafil
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 407-412
Open Access | Times Cited: 1065
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova, et al.
The Lancet (2020) Vol. 396, Iss. 10255, pp. 887-897
Open Access | Times Cited: 1063
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 615-632
Open Access | Times Cited: 1022
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, et al.
ACS Central Science (2020) Vol. 6, Iss. 10, pp. 1722-1734
Open Access | Times Cited: 930
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang, Bernardo García‐Carreras, Matt D. T. Hitchings, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 924
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson, Laura E. Rosen, James G. Shepherd, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1171-1187.e20
Open Access | Times Cited: 623
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec, Daniel Wrapp, Andrew S. Herbert, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 731-736
Open Access | Times Cited: 603
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan, James Brett Case, Emma S. Winkler, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 744-753.e4
Open Access | Times Cited: 538
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, et al.
Nature Medicine (2020) Vol. 26, Iss. 9, pp. 1422-1427
Open Access | Times Cited: 504
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 722-733.e11
Open Access | Times Cited: 480
The hallmarks of COVID-19 disease
Daolin Tang, Paul B. Comish, Rui Kang
PLoS Pathogens (2020) Vol. 16, Iss. 5, pp. e1008536-e1008536
Open Access | Times Cited: 449
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee, et al.
Nature Medicine (2020) Vol. 26, Iss. 9, pp. 1428-1434
Open Access | Times Cited: 435
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 593
Open Access | Times Cited: 426
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
Alberto L. García‐Basteiro, Gemma Moncunill, Marta Tortajada, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 412
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan, Qianqian Zheng, Hongxia Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 403
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
Ali Rostami, Mahdi Sepidarkish, Mariska Leeflang, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 3, pp. 331-340
Open Access | Times Cited: 383
Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 364
Page 1 - Next Page

Scroll to top